Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 13, Issue 11
|
pp. 15444–15458
Alterations in the RTK/Ras/PI3K/AKT pathway serve as potential biomarkers for immunotherapy outcome of diffuse gliomas
Back to article
Figure 5
(5 of 5)
−
100%
+
Figure 5.
Subgroup analysis showed the association between immunotherapy predictive biomarkers and RTK/Ras/PI3K/AKT pathway.
